{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,13]],"date-time":"2026-03-13T13:44:14Z","timestamp":1773409454461,"version":"3.50.1"},"reference-count":28,"publisher":"Elsevier BV","issue":"4","license":[{"start":{"date-parts":[[2007,10,1]],"date-time":"2007-10-01T00:00:00Z","timestamp":1191196800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2007,10,1]],"date-time":"2007-10-01T00:00:00Z","timestamp":1191196800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["American Heart Journal"],"published-print":{"date-parts":[[2007,10]]},"DOI":"10.1016\/j.ahj.2007.06.009","type":"journal-article","created":{"date-parts":[[2007,8,28]],"date-time":"2007-08-28T07:18:35Z","timestamp":1188285515000},"page":"718-724","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":32,"title":["PPAR\u03b3 gene C161T substitution is associated with reduced risk of coronary artery disease and decreased proinflammatory cytokine expression"],"prefix":"10.1016","volume":"154","author":[{"given":"Yu","family":"Liu","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Zuyi","family":"Yuan","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yan","family":"Liu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jijun","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ping","family":"Yin","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Dongqi","family":"Wang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yanni","family":"Wang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Chiharu","family":"Kishimoto","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Aiqun","family":"Ma","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.ahj.2007.06.009_bib1","doi-asserted-by":"crossref","first-page":"576","DOI":"10.1016\/S0959-437X(98)80014-2","article-title":"The nuclear receptor PPAR gamma\u2014bigger than fat","volume":"8","author":"Kliewer","year":"1998","journal-title":"Curr Opin Genet Dev"},{"key":"10.1016\/j.ahj.2007.06.009_bib2","doi-asserted-by":"crossref","first-page":"18779","DOI":"10.1074\/jbc.272.30.18779","article-title":"The organization, promoter analysis, and expression of the human PPAR gamma gene","volume":"272","author":"Fajas","year":"1997","journal-title":"J Biol Chem"},{"key":"10.1016\/j.ahj.2007.06.009_bib3","first-page":"48","article-title":"PPAR-\u03b3 dependent and independent effects on macrophage-gene expression in lipid metabolism and inflammation","volume":"7","author":"Chawla","year":"2001","journal-title":"Nature"},{"key":"10.1016\/j.ahj.2007.06.009_bib4","doi-asserted-by":"crossref","first-page":"1364","DOI":"10.4049\/jimmunol.164.3.1364","article-title":"The nuclear receptor PPAR gamma and immunoregulation: PPAR gamma mediates inhibition of helper T cell responses","volume":"164","author":"Clark","year":"2000","journal-title":"J Immunol"},{"key":"10.1016\/j.ahj.2007.06.009_bib5","doi-asserted-by":"crossref","first-page":"1097","DOI":"10.1161\/01.RES.83.11.1097","article-title":"Peroxisome proliferator\u2013activated receptor gamma activators inhibit gene expression and migration in human vascular smooth muscle cells","volume":"83","author":"Marx","year":"1998","journal-title":"Circ Res"},{"key":"10.1016\/j.ahj.2007.06.009_bib6","doi-asserted-by":"crossref","first-page":"7614","DOI":"10.1073\/pnas.95.13.7614","article-title":"Expression of the peroxisome proliferator\u2013activated receptor \u03b3 (PPAR\u03b3) in human atherosclerosis and regulation in macrophages by colony stimulating factors and oxidized low density lipoprotein","volume":"95","author":"Ricote","year":"1998","journal-title":"Proc Natl Acad Sci U S A"},{"key":"10.1016\/j.ahj.2007.06.009_bib7","doi-asserted-by":"crossref","first-page":"79","DOI":"10.1038\/34178","article-title":"The peroxisome proliferator activator-\u03b3 is a negative regulator of macrophage activation","volume":"391","author":"Ricote","year":"1998","journal-title":"Nature"},{"key":"10.1016\/j.ahj.2007.06.009_bib8","doi-asserted-by":"crossref","first-page":"82","DOI":"10.1038\/34184","article-title":"PPAR-\u03b3 agonists inhibit production of monocyte inflammatory cytokines","volume":"391","author":"Jiang","year":"1998","journal-title":"Nature"},{"key":"10.1016\/j.ahj.2007.06.009_bib9","doi-asserted-by":"crossref","first-page":"115","DOI":"10.1056\/NEJM199901143400207","article-title":"Atherosclerosis\u2014an inflammatory disease","volume":"340","author":"Ross","year":"1999","journal-title":"N Engl J Med"},{"key":"10.1016\/j.ahj.2007.06.009_bib10","doi-asserted-by":"crossref","first-page":"488","DOI":"10.1016\/j.ahj.2004.10.025","article-title":"Differential gene expression in coronary arteries from patients presenting with ischemic heart disease: further evidence for the inflammatory basis of atherosclerosis","volume":"150","author":"Satterthwaite","year":"2005","journal-title":"Am Heart J"},{"key":"10.1016\/j.ahj.2007.06.009_bib11","doi-asserted-by":"crossref","first-page":"271","DOI":"10.1053\/euhj.2001.2906","article-title":"Susceptibility-conferring polymorphic genotypes in cardiovascular multifactorial syndromes","volume":"23","author":"Swynghedauw","year":"2002","journal-title":"Eur Heart J"},{"key":"10.1016\/j.ahj.2007.06.009_bib12","doi-asserted-by":"crossref","first-page":"213","DOI":"10.1053\/meta.2003.50039","article-title":"Pro12Ala polymorphism of the PPAR-\u03b32 gene is related to increased levels of oxidized low-density lipoprotein (LDL) autoantibodies in patients with type 2 diabetes mellitus","volume":"52","author":"Gomez-Zumaquero","year":"2003","journal-title":"Metabolism"},{"key":"10.1016\/j.ahj.2007.06.009_bib13","doi-asserted-by":"crossref","first-page":"55","DOI":"10.1016\/S0168-8227(03)00161-X","article-title":"The association of Pro12Ala polymorphism in PPAR\u03b32 with lower carotid artery IMT in Japanese","volume":"62","author":"Iwata","year":"2003","journal-title":"Diabetes Res Clin Pract"},{"key":"10.1016\/j.ahj.2007.06.009_bib14","doi-asserted-by":"crossref","first-page":"859","DOI":"10.1161\/01.ATV.0000068680.19521.34","article-title":"Alanine for proline substitution in the peroxisome proliferator\u2013activated receptor \u03b3-2 (PPAR\u03b32) gene and the risk of incident myocardial infarction","volume":"23","author":"Ridker","year":"2003","journal-title":"Arterioscler Thromb Vasc Biol"},{"key":"10.1016\/j.ahj.2007.06.009_bib15","doi-asserted-by":"crossref","first-page":"588","DOI":"10.1016\/S0008-6363(99)00256-4","article-title":"Peroxisome proliferator\u2013activated receptor \u03b3 C161\u2192T polymorphism and coronary artery disease","volume":"44","author":"Wang","year":"1999","journal-title":"Cardiovasc Res"},{"key":"10.1016\/j.ahj.2007.06.009_bib16","first-page":"392","article-title":"Peroxisome proliferation\u2013activated receptor-\u03b3 ligands ameliorate experimental autoimmune myocarditis","volume":"57","author":"Yuan","year":"2003","journal-title":"Cardiovasc Res"},{"key":"10.1016\/j.ahj.2007.06.009_bib17","doi-asserted-by":"crossref","first-page":"868","DOI":"10.1097\/00005344-200406000-00017","article-title":"Peroxisome proliferator\u2013activated receptor-gamma ligands ameliorate experimental autoimmune myocarditis associated with inhibition of self-sensitive T cells","volume":"43","author":"Yuan","year":"2004","journal-title":"J Cardiovasc Pharmacol"},{"key":"10.1016\/j.ahj.2007.06.009_bib18","doi-asserted-by":"crossref","first-page":"1032","DOI":"10.1016\/j.ahj.2003.12.035","article-title":"Peroxisome proliferator\u2013activated receptor-gamma agonist rosiglitazone reduces circulating platelet activity in patients without diabetes mellitus who have coronary artery disease","volume":"147","author":"Sidhu","year":"2004","journal-title":"Am Heart J"},{"key":"10.1016\/j.ahj.2007.06.009_bib19","doi-asserted-by":"crossref","first-page":"245","DOI":"10.1016\/S0021-9150(99)00371-8","article-title":"Atherosclerotic arterial remodeling and the location of macrophages and matrix metalloproteinase 1, 2 and 9 in the human coronary artery","volume":"150","author":"Pasterkamp","year":"2000","journal-title":"Atherosclerosis"},{"key":"10.1016\/j.ahj.2007.06.009_bib20","doi-asserted-by":"crossref","first-page":"572","DOI":"10.1016\/S0008-6363(02)00710-1","article-title":"Overexpression of matrix metelloproteinase-9 promotes intravascular thrombus formation in porcine coronary arteries in vivo","volume":"57","author":"Morishige","year":"2003","journal-title":"Cardiovasc Res"},{"key":"10.1016\/j.ahj.2007.06.009_bib21","doi-asserted-by":"crossref","first-page":"276","DOI":"10.1016\/j.ahj.2004.09.032","article-title":"Patterns of inflammation associated with peripheral arterial disease: the InCHIANTI study","volume":"150","author":"McDermott","year":"2005","journal-title":"Am Heart J"},{"key":"10.1016\/j.ahj.2007.06.009_bib22","doi-asserted-by":"crossref","first-page":"693","DOI":"10.2337\/diabetes.53.3.693","article-title":"Inflammatory markers and risk of developing type 2 diabetes in women","volume":"53","author":"Hu","year":"2004","journal-title":"Diabetes"},{"key":"10.1016\/j.ahj.2007.06.009_bib23","doi-asserted-by":"crossref","first-page":"372","DOI":"10.1172\/JCI118802","article-title":"Polymorphisms at the 59-end of the apolipoprotein AI gene and severity of coronary artery disease","volume":"98","author":"Wang","year":"1996","journal-title":"J Clin Invest"},{"key":"10.1016\/j.ahj.2007.06.009_bib24","doi-asserted-by":"crossref","first-page":"431","DOI":"10.1097\/00019501-200309000-00003","article-title":"Serum tumor necrosis factor-alpha, interleukin-2 and interleukin-10 activation in stable angina and acute coronary syndromes","volume":"14","author":"Mizia-Stec","year":"2003","journal-title":"Coron Artery Dis"},{"key":"10.1016\/j.ahj.2007.06.009_bib25","doi-asserted-by":"crossref","first-page":"337","DOI":"10.1080\/00365510260296483","article-title":"Serum matrix metalloproteinase-9 concentration in angiographically assessed coronary artery disease","volume":"62","author":"Kalela","year":"2002","journal-title":"Scand J Clin Lab Invest"},{"key":"10.1016\/j.ahj.2007.06.009_bib26","doi-asserted-by":"crossref","first-page":"211","DOI":"10.1067\/mhj.2001.112238","article-title":"Plasma levels of matrix metelloproteinase-9 and tissue inhibitor of metelloproteinase-1 are increased in the coronary circulation in patients with acute coronary syndrome","volume":"141","author":"Inokubo","year":"2001","journal-title":"Am Heart J"},{"key":"10.1016\/j.ahj.2007.06.009_bib27","doi-asserted-by":"crossref","first-page":"435","DOI":"10.1093\/hmg\/7.3.435","article-title":"A genetic polymorphism of the peroxisome proliferator activator gamma gene influences plasma leptin levels in obese humans","volume":"7","author":"Meirhaeghe","year":"1998","journal-title":"Hum Mol Genet"},{"key":"10.1016\/j.ahj.2007.06.009_bib28","first-page":"241","article-title":"Regulation of macrophage gene expression by peroxisome proliferator activator receptor \u03b3: implication for cardiovascular disease","volume":"10","author":"Totonoz","year":"1999","journal-title":"Curr Opin Lipidol"}],"container-title":["American Heart Journal"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0002870307005091?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0002870307005091?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,11]],"date-time":"2025-09-11T05:33:51Z","timestamp":1757568831000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0002870307005091"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2007,10]]},"references-count":28,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2007,10]]}},"alternative-id":["S0002870307005091"],"URL":"https:\/\/doi.org\/10.1016\/j.ahj.2007.06.009","relation":{},"ISSN":["0002-8703"],"issn-type":[{"value":"0002-8703","type":"print"}],"subject":[],"published":{"date-parts":[[2007,10]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"PPAR\u03b3 gene C161T substitution is associated with reduced risk of coronary artery disease and decreased proinflammatory cytokine expression","name":"articletitle","label":"Article Title"},{"value":"American Heart Journal","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ahj.2007.06.009","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2007 Published by Mosby, Inc.","name":"copyright","label":"Copyright"}]}}